|
Summary:
|
Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products. Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir.. E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns
|
|
File Size:
|
274KB
|
|
Type:
|
Files / Images
|
|
Created:
|
23 November 2023
|
|
Last Modified:
|
23 November 2023
|
